Coriolis Pharma, a globally operating service provider in formulation research and development of biopharmaceuticals, and RheaVita, a supplier of continuous freeze-drying technology for biopharmaceuticals, have joined forces to advance the novel technology for drug product development of biologics, in particular novel modalities. RheaVita’s continuous freeze-drying technology integrates all traditional freeze-drying steps into a continuous production line. According to the company, this...